GoodRx Holdings, Inc. (GDRX) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
GDRX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GDRX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 82.1% | 13.4% | 3.8% |
| 2024 | 93.9% | 8.3% | 2.1% |
| 2023 | 91.1% | -3.6% | -1.2% |
| 2022 | 91.5% | 0.2% | -4.3% |
| 2021 | 93.7% | 1.8% | -3.4% |
Download Data
Export GDRX earnings history in CSV or JSON format
Free sign-in required to download data
GoodRx Holdings, Inc. (GDRX) Earnings Overview
As of May 8, 2026, GoodRx Holdings, Inc. (GDRX) reported trailing twelve-month net income of $29M, reflecting +104.1% year-over-year growth. The company earned $0.09 per diluted share over the past four quarters, with a net profit margin of 3.8%.
Looking at the long-term picture, GDRX's historical earnings data spans multiple years. The company achieved its highest annual net income of $66M in fiscal 2019.
GoodRx Holdings, Inc. maintains positive profitability with a gross margin of 82.1%, operating margin of 13.4%, and net margin of 3.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including HIMS ($128M net income, 5.5% margin), TDOC (-$171M net income, -7.9% margin), OPRX ($5M net income, 4.7% margin), GDRX has room to improve margins relative to the peer group. Compare GDRX vs HIMS →
GDRX Earnings vs Peers
Earnings metrics vs comparable public companies
GDRX Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $30M | +85.7% | $107M | $0.09 | 3.8% | 13.4% |
| 2024 | $16M | +284.8% | $66M | $0.04 | 2.1% | 8.3% |
| 2023 | -$9M | +73.0% | -$27M | $-0.02 | -1.2% | -3.6% |
| 2022 | -$33M | -30.0% | $2M | $-0.08 | -4.3% | 0.2% |
| 2021 | -$25M | +91.4% | $13M | $-0.06 | -3.4% | 1.8% |
| 2020 | -$294M | -544.6% | -$276M | $-1.07 | -53.3% | -50.1% |
| 2019 | $66M | +50.8% | $140M | $0.12 | 17.0% | 36.0% |
| 2018 | $44M | - | $77M | $0.12 | 17.6% | 31.0% |
See GDRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GDRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GDRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGDRX — Frequently Asked Questions
Quick answers to the most common questions about buying GDRX stock.
Is GDRX growing earnings?
GDRX EPS is $0.09, with earnings growth accelerating to +104.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $29M.
What are GDRX's profit margins?
GoodRx Holdings, Inc. net margin is +3.8%, with operating margin at +13.4%. Below-average margins reflect competitive or cost pressures.
How consistent are GDRX's earnings?
GDRX earnings data spans 2018-2025. The accelerating earnings trend is +104.1% YoY. Historical data enables comparison across business cycles.